Should you buy INCY stock?

Last updated:

Based on market data through , StockInvest.us rates Incyte Corporation (INCY) as a Buy Candidate with a technical score of 1.09 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Buy signal since
  • Price since signal Up 15.57%
  • 3-month trend forecast Up 29.47%
  • Buy Candidate 1.09
AI Analysis AI Analysis of INCY AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add INCY to Watchlist?
Some Reasons Why To Add INCY:
  • High gross margin of 92.6%
  • Healthy interest coverage ratio of 790.6x
  • Strong operating margin of 31.6%
PDF

Incyte Corporation stock price ended at $119.80 on Wednesday, after losing 0.663%
(Market data through Aug 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 22, 2026 Gain 15.57%

The Incyte Corporation stock price fell by -0.663% on the last day (Wednesday, 5th Aug 2026) from $120.60 to $119.80. During the last trading day the stock fluctuated 4.25% from a day low at $119.49 to a day high of $124.57. The price has been going up and down for this period, and there has been a 3.46% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -197 thousand shares and in total, 2 million shares were bought and sold for approximately $211.80 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 29.47% during the next 3 months and, with a 90% probability hold a price between $147.20 and $172.00 at the end of this 3-month period.

INCY Signals & Forecast

The Incyte Corporation stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $122.62. On a fall, the stock will find some support from the long-term average at approximately $114.80. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 28, 2026, and so far it has fallen -7.80%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Incyte Corporation stock

On the downside, the stock finds support just below today's level from accumulated volume at $113.75 and $100.64. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Incyte Corporation finds support just below today's level at $113.75. If this is broken, then the next support from accumulated volume will be at $100.64 and $98.22.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $5.08 between high and low, or 4.25%. For the last week, the stock has had daily average volatility of 3.60%.

Our recommended stop-loss: $112.73 (-5.90%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (INCY) For The Upcoming Trading Day Of Thursday 6th

For the upcoming trading day on Thursday, 6th we expect Incyte Corporation to open at $121.29, and during the day (based on 14 day Average True Range), to move between $117.68 and $121.92, which gives a possible trading interval of +/-$4.23 (+/-3.60%) up or down from last closing price. If Incyte Corporation takes out the full calculated possible swing range there will be an estimated 3.60% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $122.99 (2.66%) than the support at $113.75 (5.05%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Incyte Corporation stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Incyte Corporation stock to perform well in the short-term.

Current score: 1.091 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 6, 2026 - $121.29 ( 1.24%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

INCY Performance

Trading levels for INCY

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 126.37 5.48%
R2 124.43 3.86%
R1 123.23 2.86%
Price 119.80
S1 119.35 -0.379%
S2 118.15 -1.38%
S3 116.21 -3.00%

Accumulated Volume Support & Resistance Levels

Level Price
R3 129.93 8.46%
R2 127.10 6.09%
R1 122.99 2.66%
Price 119.80
S1 113.75 -5.05%
S2 100.64 -15.99%
S3 98.22 -18.01%

FAQ

What is the symbol for Incyte Corporation Stock and on which exchange is it traded?
The symbol for Incyte Corporation is INCY and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Incyte Corporation Stock?
Based on market data through Aug 05, 2026, StockInvest.us rates Incyte Corporation (INCY) as a Buy Candidate with a technical score of 1.09 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Buy signal began on Jun 22, 2026, the price has risen 15.57%. The current 3-month trend forecast projects a rise of 29.47%.

How to buy Incyte Corporation Stock?
Incyte Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Incyte Corporation Stock.

What's the current price of Incyte Corporation Stock?
As of the end of day on the Aug 05, 2026, the price of an Incyte Corporation (INCY) share was $119.80.

What is the 52-week high and low for Incyte Corporation Stock?
The 52-week high for Incyte Corporation Stock is $132.58 and the 52-week low is $76.45.

What is the market capitalization of Incyte Corporation Stock?
As of the Aug 05, 2026, the market capitalization of Incyte Corporation is 24.283B.

When is the next earnings date for Incyte Corporation?
The upcoming earnings date for Incyte Corporation is Oct 27, 2026.
Click to get the best stock tips daily for free!
ABOUT INCYTE CORPORATION
Incyte
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr...
GOLDEN STAR
Ticker Change Signal Date
FCX
$62.63
7.46% Jul 31
MC
$67.08
2.40% Jul 31
ARW
$212.85
6.96% Jul 30
BIIB
$202.19
3.10% Jul 24
F
FERG
$230.67
10.77% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE